Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hepatitis × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 23 Lymphoma 11 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Non-Hodgkin 8 Prostatic Neoplasms 7 Lymphoma, Follicular 7 Leukemia 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Neoplasms, Plasma Cell 4 Lymphoma, Mantle-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myasthenia Gravis 2 Lymphoma, Large-Cell, Immunoblastic 2 Immunoblastic Lymphadenopathy 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinal Cord Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Plasmablastic Lymphoma 1 Neoplasms, Experimental 1 Neoplasms 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Neoadjuvant Therapy 1 Myelodysplastic Syndromes 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡